Chemistry for peptide and protein PEGylation (Q34674747)

3 August 2017

1 reference

title

Chemistry for peptide and protein PEGylation (English)

1 reference

3 August 2017

Roberts MJ

1 reference

3 August 2017

Bentley MD

series ordinal

1 reference

3 August 2017

Harris JM

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Advanced Drug Delivery Reviews

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

459-476

1 reference

Biopharmaceutical benchmarks

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

LABORATORY SYNTHESIS OF POLYETHYLENE GLYCOL DERIVATIVES

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Peptide and protein PEGylation: a review of problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Selective synthesis of heterobifunctional poly(ethylene glycol) derivatives containing both mercapto and acetal terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

A Theory for the Displacement of Proteins and Viruses with Polyethylene Glycol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Long-acting growth hormones produced by conjugation with polyethylene glycol.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

A simplified method for the preparation of succinimidyl carbonate polyethylene glycol for coupling to proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

A new procedure for the synthesis of polyethylene glycol-protein adducts; Effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and α2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Instability of succinyl ester linkages in O2'-monosuccinyl cyclic AMP-protein conjugates at neutral pH.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Characterization and stability of N-terminally PEGylated rhG-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Site-directed pegylation of recombinant interleukin-2 at its glycosylation site

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Preparation of characterization of poly(ethylene glycol) vinyl sulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Protected thiol-polyethylene glycol: a new activated polymer for reversible protein modification

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

The crystal structure of human interferon beta at 2.2-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Attachment of degradable poly(ethylene glycol) to proteins has the potential to increase therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

The preparation and properties of novel reversible polymer-protein conjugates. 2-omega-Methoxypolyethylene (5000) glycoxymethylene-3-methylmaleyl conjugates of plasminogen activators

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Drug delivery systems employing 1,6-elimination: releasable poly(ethylene glycol) conjugates of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Synthesis of poly(ethylene oxide) with heterobifunctional reactive groups at its terminals by an anionic initiator

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Heterobifunctional Poly(ethylene oxide): Synthesis of .alpha.-Methoxy-.omega.-amino and .alpha.-Hydroxy-.omega.-amino PEOs with the Same Molecular Weights

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

Formyl-Ended Heterobifunctional Poly(ethylene oxide): Synthesis of Poly(ethylene oxide) with a Formyl Group at One End and a Hydroxyl Group at the Other End

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

A branched monomethoxypoly(ethylene glycol) for protein modification

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900022-4

7 January 2021

10.1016/S0169-409X(02)00022-4

Identifiers

DOI

1 reference

3 August 2017

1 reference